All hands to the pumps – how bacteria evolve resistance to antibiotics
Bacteria can rapidly evolve resistance to antibiotics by adapting special pumps to flush them out of their cells, say researchers from the Quadram Institute and University of East Anglia.
The findings, published in the journal...
TEAM TASKED WITH GIVING US FIVE EXTRA YEARS OF HEALTH AND HAPPINESS
The National Innovation Centre for Ageing is based in The Catalyst, the stunning new building with a glass façade rearing like a horse’s head out of the 24-acre, £350m science park that is the...
Protecting Digital Medtech Innovation
For many years the medical technology (medtech) sector has been at the forefront of innovation and the Covid-19 pandemic has not slowed it down, with new technology quickly being developed to test for, prevent...
Superpower or Clark Kent: what is the future for UK life sciences?
Ivor Campbell of Snedden Campbell explores the scale, activities and pulling power of UK companies compared with those of similar size and scale elsewhere, including in the US and Asia Pacific region.
Because our prime...
NETPark – A Jewel in the region’s business crown
NETPark is a globally significant science park where innovation is the order of every day. It is where thinkers go to think, inventors go to invent, and doers go to do.
In the almost 20...
Radiation in cancer diagnosis – keeping your enemies closer
It’s a remarkable paradox of cancer treatment that radiation, a well-known cause of cancer, is also a cornerstone treatment. Safe doses of radiation can also play a part in diagnosis. Scientists working within the...
Breaking through cardiovascular disease
Professor Metin Avkiran, Associate Medical Director at the British Heart Foundation (BHF) explains the work they are doing to find the next breakthrough treatment for cardiovascular disease.
Since the BHF was formed over 50 years...
Causality in Neuroscience
‘Abbexa is a dedicated manufacturer and worldwide supplier of biological tools such as ELISA kits, antibodies, proteins, enzymes and other reagents and products designed for use in research’.
Causality is often the end goal of...
Biosimilars and Patents
Leonita Paulraj - Associate, AA Thornton
The majority of the world’s biggest selling medicines can be classified as “biologics” or “biopharmaceuticals”. Such medicines contain one or more biologically active product produced from (or containing components of)...
Revealed: the first wiring map of neurons in insect brain
Researchers have built the first ever map showing every single neuron and their wiring in the brain of the fruit fly larva.
This huge step forwards in science will ultimately help us understand the basic...
Health WildCard winner builds library of biological profiles
Digital digital health company iLoF has received $5m in funding to accelerate its mission of improving access to personalised medicine for millions of people living with complex diseases, such as Alzheimer’s.
Initially backed by EIT...
Artificial intelligence yields new antibiotic
A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.
Using a machine-learning algorithm, MIT researchers have identified a powerful new antibiotic compound. In laboratory tests, the drug killed...
Campus is well placed as Northern bioeconomy prepares for strong growth
The bioeconomy in the North of England stands on the cusp of signifigant expansion and one of the science parks which is ready to play its part is the National Agri-Food Innovation Campus (NAFIC).
Situated...
Impact of latest innovative gastroenterology research for patient benefit
According to the British Society of Gastroenterology, the burden of gastrointestinal and liver disease is heavy for patients, the NHS, and the economy. Gastrointestinal disease is the third most common cause of death, and...
UK Government invests £5m to develop ‘library’ of MRNA vaccines
CPI has received a £5 million investment to support the development of an mRNA ‘vaccine library’ as part of the Government’s vaccine support package announced in the Budget by the chancellor, Rishi Sunak.
The vaccine...
Delivering real impact to the world of bioscience
Since it opened in 2019, the National Horizons Centre has quickly established itself as a vital linchpin helping drive forward the life sciences sector across the UK.
Through research, partnerships and training , the National...